Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

118,375 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction to: Comparison of the Amplification Refractory Mutation System, Super Amplification Refractory Mutation System, and Droplet Digital PCR for T790 M Mutation Detection in Non-small Cell Lung Cancer after Failure of Tyrosine Kinase Inhibitor Treatment.
Zhu L, Zhang S, Xun Y, Jiang Y, Xia B, Chen X, Wang L, Jiang H, Ma S. Zhu L, et al. Among authors: chen x. Pathol Oncol Res. 2018 Oct;24(4):951. doi: 10.1007/s12253-018-0421-9. Pathol Oncol Res. 2018. PMID: 29948611 Free article.
Comparison of the Amplification Refractory Mutation System, Super Amplification Refractory Mutation System, and Droplet Digital PCR for T790 M Mutation Detection in Non-small Cell Lung Cancer after Failure of Tyrosine Kinase Inhibitor Treatment.
Zhu L, Zhang S, Xun Y, Jiang Y, Xia B, Chen X, Wang L, Jiang H, Ma S. Zhu L, et al. Among authors: chen x. Pathol Oncol Res. 2018 Oct;24(4):843-851. doi: 10.1007/s12253-017-0286-3. Epub 2017 Sep 3. Pathol Oncol Res. 2018. PMID: 28868565 Free article.
Epidermal growth factor receptor (EGFR) T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: a prospective observational study.
Zhang S, Zhu L, Xia B, Chen E, Zhao Q, Zhang X, Chen X, Chen X, Ma S. Zhang S, et al. Among authors: chen e, chen x. Cancer Commun (Lond). 2018 May 22;38(1):28. doi: 10.1186/s40880-018-0303-2. Cancer Commun (Lond). 2018. PMID: 29789021 Free PMC article. Clinical Trial.
118,375 results
You have reached the last available page of results. Please see the User Guide for more information.